1. Home
  2. GHLD vs DVAX Comparison

GHLD vs DVAX Comparison

Compare GHLD & DVAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GHLD
  • DVAX
  • Stock Information
  • Founded
  • GHLD 1960
  • DVAX 1996
  • Country
  • GHLD United States
  • DVAX United States
  • Employees
  • GHLD N/A
  • DVAX N/A
  • Industry
  • GHLD Finance: Consumer Services
  • DVAX Biotechnology: Pharmaceutical Preparations
  • Sector
  • GHLD Finance
  • DVAX Health Care
  • Exchange
  • GHLD Nasdaq
  • DVAX Nasdaq
  • Market Cap
  • GHLD 1.2B
  • DVAX 1.2B
  • IPO Year
  • GHLD 2020
  • DVAX 2004
  • Fundamental
  • Price
  • GHLD $19.86
  • DVAX $11.19
  • Analyst Decision
  • GHLD Hold
  • DVAX Buy
  • Analyst Count
  • GHLD 5
  • DVAX 4
  • Target Price
  • GHLD $18.88
  • DVAX $26.50
  • AVG Volume (30 Days)
  • GHLD 35.0K
  • DVAX 1.9M
  • Earning Date
  • GHLD 11-05-2025
  • DVAX 11-05-2025
  • Dividend Yield
  • GHLD 3.78%
  • DVAX N/A
  • EPS Growth
  • GHLD N/A
  • DVAX N/A
  • EPS
  • GHLD 1.99
  • DVAX N/A
  • Revenue
  • GHLD $1,269,928,000.00
  • DVAX $330,514,000.00
  • Revenue This Year
  • GHLD $1.42
  • DVAX $23.23
  • Revenue Next Year
  • GHLD $22.36
  • DVAX $16.57
  • P/E Ratio
  • GHLD $9.97
  • DVAX N/A
  • Revenue Growth
  • GHLD 53.03
  • DVAX 26.73
  • 52 Week Low
  • GHLD $11.21
  • DVAX $9.20
  • 52 Week High
  • GHLD $23.57
  • DVAX $14.63
  • Technical
  • Relative Strength Index (RSI)
  • GHLD 43.02
  • DVAX 59.74
  • Support Level
  • GHLD $19.93
  • DVAX $10.97
  • Resistance Level
  • GHLD $19.97
  • DVAX $11.26
  • Average True Range (ATR)
  • GHLD 0.05
  • DVAX 0.39
  • MACD
  • GHLD -0.01
  • DVAX 0.00
  • Stochastic Oscillator
  • GHLD 18.75
  • DVAX 83.11

About GHLD Guild Holdings Company

Guild Holdings Co is a growth-oriented mortgage company. It operates in two segments; The origination segment operates its loan origination business throughout the United States. It is responsible for loan origination, acquisition, and sale activities. This segment is further divided into retail and correspondent channel, and The servicing segment provides a steady stream of cash flow to support the origination segment more importantly it allows for the Company to build long-standing client relationships that drive repeat and referral business back to the origination segment to recapture the client's next mortgage transaction. It is responsible for the servicing activities of all loans in its servicing portfolio. It generates a majority of its revenue from the Origination segment.

About DVAX Dynavax Technologies Corporation

Dynavax Technologies Corp is a biopharmaceutical company. The company focuses on leveraging the power of the body's innate and adaptive immune responses through toll-like receptor stimulation. Its current product candidates are being investigated for use in multiple cancer indications as a vaccine for the prevention of HEPLISAV-B (Hepatitis B Vaccine (Recombinant), Adjuvanted), operates in the business segment of discovery, development, and commercialization of novel vaccines. Its Toll-like Receptor Immune Modulation Platform technology plays a vital role in innate immunity and subsequent adaptive immunity. The company generates the vast majority of its revenue from the sale of its CpG 1018 product and HEPLISAV-B.

Share on Social Networks: